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Ubiquitin-protein conjugates are found by immunogold electron microscopy to be enriched (12-fold) in the lysosomal compartment of 3T3-Ll 
fibroblasts. Treatment of fibroblasts with the cysteine protease inhibitor E-64 leads to an expansion of the lysosomal compartment and as a result 
an increase in the cellular content of ubiquitin-protein conjugates. There is no change in the specific enrichment of ubiquitin-protein conjugates 
in the lysosomal compartment following E-64 treatment. The results suggest hat some ubiquitin-protein conjugates may normally be degraded 
lysosomally following sequestration by microautophagy and imply that protein ubiquitination may be one of the signals for protein uptake into 
lysosomes. 
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1. INTRODUCTION 2. MATERIALS AND METHODS 
The metabolism of ubiquitin has been extensively 
3T3-Ll fibroblasts were cultured and inhibitors administered as 
described previously [lo]. Cells were harvested by trypsinization, 
washed with phosphate-buffered saline then fixed in 2% v/v parafor- 
maldehyde/O.Wo glutaraldehyde containing 1% w/v sucrose and 
2 mM CaC12. After post-fixation and block-staining with 1% w/v 
0~04 and 2.5% w/v uranyl acetate the specimens were dehydrated in 
graded ethanol and embedded in araldite. Cells for immunogold elec- 
tron microscopy were submitted to the same procedure except for the 
omission of osmification. Immunogold labelling was carried out by 
a post-embedding biotin-streptavidin bridge method [l l] using 
affinity-purified rabbit antibody to ubiquitin-protein conjugates [12] 
(1: 20 dilution), affinity-purified rabbit antibody to porcine heart lac- 
tate dehydrogenase (1: 5 dilution) and biotinylated goat antibody to 
rabbit IgG (Vector Labs, Peterborough, England; 1: 100 dilution) 
and streptavidin-gold (10 nm, Sigma, Poole, England, 1:20 dilu- 
tion). lmmunostained sections were post-fixed with 0~04 and 
counterstained with uranyl acetate and lead citrate. 
studied in reticulocyte lysates where it has been shown 
to be a cofactor in the rapid extralysosomal ATP- 
dependent degradation of proteins (reviewed in [l]). 
However, protein ubiquitination is not only a prere- 
quisite for rapid elimination since in nucleated cells ubi- 
quitinated proteins are found in the nucleus [2] and 
plasma membrane [3-61. We have recently shown by 
biochemical methods that ubiquitinated protein con- 
jugates accumulate in the lysosome compartment in 
fibroblasts where lysosomal thiol cathepsins have been 
specifically inhibited [7-lo]. At that time imm,unoblot- 
ting and immunogold microscopical examination of 
untreated cells suggested that ubiquitin-protein con- 
jugates might be normally concentrated in the 
lysosomal compartment. We have now been able to 
demonstrate by quantitative immunogold electron 
microscopy that ubiquitin protein conjugates are in- 
deed selectively enriched in the lysosomal compartment 
(12-fold) in normal fibroblasts relative to all other 
organelles. The data indicate a new function for ubi- 
quitin in nucleated cells, namely that protein ubi- 
quitination may serve as a signal for protein uptake 
into the lysosomal system. 
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The total cytoplasmic and lysosomal areas and gold particle den- 
sities were estimated [13] using at least 30 different randomly selected 
electron micrographs of ultrathin sections (covering at least 
1000~m2). Gold particle numbers from sections treated with non- 
immune rabbit serum were subtracted from numbers obtained from 
sections treated with the indicated rabbit primary antibodies (a total 
of 2829 for anti-ubiquitin protein and 10013 for anti-LDH in un- 
treated cells and a total of 7270 anti-ubiquitin protein conjugate 
specific gold particles and 8836 anti-LDH specific gold particles in 
E-6Ctreated cells) and used to calculate the densities hown in tables 
1 and 2. 
3. RESULTS AND DISCUSSION 
Knowledge of the distribution of ubiquitin-protein 
conjugates throughout the topologically defined com- 
partments of nucleated mammalian cells is of obvious 
importance for our understanding of the role of protein 
ubiquitination. Rabbit antiserum which recognised 
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Table 1 
Immunogold quantitation of ubiquitin-protein conjugates and lactate 
dehydrogenase in 3T3-Ll cells 
Primary Immunospecific gold particle density 
antibody (gold particles/~m*) 
Total Extra-lysosomal Lysosomal Relative 
cytoplasm cytoplasm compartment density 
(Cyt) (Cyt minus Lys) (Lys) (Lys/Cyt) 
Anti-ubiquitin 
protein 
conjugates 2.7-0.9 2.2-0.9 33.3-7.0 12.3 
Anti-lactate 
dehydro- 
genase 9.6-1.3 9.6-1.4 8.3-3.3 0.9 
Table 2 
Immunogold quantitation of ubiquitin-protein conjugates and lactate 
dehydrogenase in 3T3-Ll cells treated for 48 h with 0.5 mM E-64 
Primary Immunospecific gold particle density 
antibody (gold particles/pm*) 
Total Extra-lysosomal Lysosomal Relative 
cytoplasm cytoplasm compartment density 
(Cyt) (Cyt minus Lys) (Lys) (Lys/Cyt) 
Anti-ubiquitin 
protein 
conjugates 7.2-2.1 3.9-1.2 32.7-10.5 4.5 
Anti-lactate 
dehydro- 
genase 8.5-1.8 8.7-2.0 7.5-2.3 0.9 
Measurements of total cytoplasmic and lysosomal areas and 
immunospecific gold particles were as described in section 2 
ubiquitin-protein conjugates was raised as described 
previously [ 12,141. Ubiquitin-protein conjugates were 
readily detectable and free ubiquitin only poorly 
recognised on immunoblots by affinity-purified an- 
tibody [lo]. Numerous immunogold particles were 
observed over sections of freshly prepared rabbit 
reticulocytes probed with this antibody (not shown). 
Disassembly of ubiquitin-protein conjugates by deple- 
tion of reticulocyte ATP following incubation with 
dinitrophenol and deoxyglucose resulted in very few 
immunogold particles over the resulting sections (not 
shown) suggesting that in contrast to conjugated ubi- 
quitin, free ubiquitin is poorly detected, if at all, in 
ultrathin sections by this antibody. Examination of sec- 
tions of 3T3-Ll mouse fibroblast cultures probed with 
rabbit antibody to ubiquitin-protein conjugates reveals 
the presence of ubiquitin-protein conjugates 
throughout the cytoplasm and nucleus of cultured 
fibroblasts (fig. la). Structures identified as com- 
ponents of the lysosomal system morphologically as 
well as biochemically [ 10,151 were found to be rich in 
gold particles, indicating the presence of ubiquitin- 
protein conjugates in this cell compartment (fig.lb). 
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The presence of ubiquitin-protein conjugates in the 
lumenal space of the lysosomal compartment is surpris- 
ing given the apparent cytosolic localisation of the en- 
zymes of ubiquitination and proposed role of 
ubiquitination in targetting conjugated proteins for 
degradation by a cytosolic large molecular weight pro- 
tease [ 16,171. Gold particles indicating ubiquitin- 
protein conjugates were also detected in the nucleus 
and occasionally the Golgi apparatus of 3T3-Ll cells, 
but at much lower densities than in the lysosomal ap- 
paratus (not shown). 
Morphometric quantitation of ubiquitin-protein con- 
jugate distribution revealed that the ubiquitin-protein 
conjugates are normally selectively enriched 12-fold in 
the lysosomal compartment compared to the total 
cytoplasm (table 1). Lactate dehydrogenase (LDH) was 
used both as a marker for the cytosol and to estimate 
the uptake of cytosolic constituents into the lysosomal 
compartment by a non-selective mechanism. Im- 
munogold detection demonstrated that LDH is evenly 
distributed throughout the cytoplasm, with the concen- 
tration in the lysosomal compartment being similar to 
that in the extra-lysosomal cytoplasm (table 1) which 
would be expected if this protein is lysosomally se- 
questered by a non-selective pathway. In contrast the 
high specific enrichment of ubiquitin-protein con- 
jugates in the lysosomal compartment (table 1) suggests 
that ubiquitin-protein conjugates are sequestered in a 
selective fashion and implies that ubiquitination nor- 
mally promotes lysosomal sequestration of proteins. 
Treatment of cultured fibroblasts for 48 h with the 
membrane-impermeant cysteine protease inhibitor 
E-64, which enters cells by pinocytosis [18], leads to in- 
hibition of lysosomal protein degradation [lo] and a 
large expansion in the cytoplasmic volume fraction oc- 
cupied by the lysosomal compartment (11.8% com- 
pared to 1.7% in untreated cells, i.e. 7-fold, P < O.OOl), 
mostly in the form of multi-vesicular dense bodies 
(MVDB; fig.ld and [19]). The expanded lysosomal 
compartment contains ubiquitin-protein conjugates as 
detected by immunoblotting of electrophoretograms 
[lo] and immunogold electron microscopy (fig. lc) 
largely accounting (i.e. 75%) for the overall increase in 
the total cytoplasmic content of ubiquitin-protein con- 
jugates (2.7 vs 7.2 gold particles/pm*, P < 0.001; tables 
1 and 2). The specific enrichment of ubiquitin-protein 
conjugates in the lysosome-related compartment re- 
mained unchanged following E-64 treatment (approx- 
imately 33 gold particles/pm*, tables 1 and 2) indicating 
that E-64 treatment does not promote ubiquitin-protein 
uptake by the lysosomal system. 
We have also observed a substantial increase in 
polyubiquitin mRNA following E-64 treatment (not 
shown). This may indicate increased cytosolic protein 
ubiquitination in response to E-64 treatment. There is 
an increase in the extra-lysosomal density of anti- 
ubiquitin protein conjugate immunospecific gold par- 
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Fig.1. Ubiquitin-protein conjugate immunogold electron microscopy of 3T3-Ll fibroblasts. Gold particles, indicating the presence of ubiquitin- 
protein conjugates, were detected in the extra-lysosomal cytoplasm (C), nucleus (N) and in multi-vesicular lysosomal bodies (L) of untreated cells 
(a, arrows). Electron-dense lysosomal bodies in untreated cells are also enriched in ubiquitin-protein conjugates (b). Treatment of cells for 48 h 
with 0.5 mM E-64 leads to the appearance of numerous electron-dense multivesicular bodies (MVDB; c, d, e, f, g) which are enriched in ubiquitin- 
protein conjugates (c, e, f, g). Gold particles can be seen close to the cytoplasmic surface of MVDB (c, e), in areas of MVDB surface invagination 
(f) and close to the lumenal surface of the MVDB limiting membrane (g). The multivesicular structure and surface invaginations present in MVDBs 
can clearly be seen in samples processed for normal electron microscopy (d). (Magnification: a: x 31200; b: x 67200; c: x 52200; d: x 40800; 
e: x 63800; f: x 78300; g: x 56000). 
titles following E-64 treatment (3.9 vs 2.2 par- 
ticles/pm?, P < 0.001; table 2 vs table 1). The increase 
in extra-lysosomal ubiquitin-protein conjugates could 
be due to slowed sequestration into the functionally 
compromised lysosomal system. The increase in 
polyubiquitin gene expression could result from the 
cells attempt to maintain the relative concentrations of 
cytosolic free ubiquitin and ubiquitin-protein con- 
jugates [20]. This would imply that E-64 leads to the 
trapping in conjugated form in the lysosome of ubi- 
quitin which under normal conditions can recycle out 
to the cytosol. 
Examination of the electron micrographs (fig. lc,e; 
arrows) shows that groups of gold particles can be 
found in the cytosolic space close to the surface of the 
limiting membrane of MVDB. The limiting membrane 
of the MVDB can be seen invaginating in many cases 
(fig.ld,f). These observations indicate that the uptake 
of ubiquitin-protein conjugates, perhaps as aggregates, 
is occurring by selective microautophagy [21]. Alter- 
native mechanisms for the sequestration of ubiquitin- 
protein conjugates into the lysosome related system in- 
cludes by endocytosis of ubiquitinated cell surface pro- 
teins [3-61 or fusion of ubiquitin-protein conjugate 
containing secretory vesicles with components of the 
lysosomal system. However, the presence of cytosolic 
ubiquitin-protein conjugates close to the limiting mem- 
brane of MVDB (fig.le,f) indicates that some con- 
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jugates are sequestered into the lysosomal 
compartment from the cytosolic space. Whatever the 
mechanism whereby ubiquitinated proteins enter the 
lysosomal system, the observations described here sug- 
gest that yet another role may be added to ubiquitin’s 
growing repertoire of intracellular functions. Ubiquitin 
may have a pivotal role in the two major systems of 
protein catabolism in nucleated cells. Such a role would 
explain why ubiquitin is only found in eukaryotic cells 
and why the protein is found in cytosolic and vesicular 
bodies in a variety of human neurodegenerative 
diseases where impairments of protein catabolism may 
occur [9,22-271. 
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